Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 20 December to Question 102798 on Streptococcus: Screening, whether he expects the Group B Strep trial to report before the end of 2024.
The clinical and cost-effectiveness of testing for Group B Streptococcus: a cluster randomised trial with economic and acceptability evaluations (GBS3) trial is currently still recruiting participants. We expect these findings, as with all research funded via the National Institute for Health and Care Research, to be published following a full analysis of the trial data.